Skip to main content
Timothy Henrich

Timothy Henrich

University of California, San Francisco
United States

Timothy Henrich’s laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic, and stem cell transplantation approaches to HIV-1 cure.

They are also involved in designing and implementing novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.

Most recently, Timothy Henrich studied the long-term inflammatory and immunological sequalae of SARS-CoV-2 infection and human herpes virus reactivation during acute viral infections.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.